APA (7th ed.) Citation

D, C., S, C., L, S., A, T., A, Z., M, M., . . . C, C. (2025). Diagnostic relevance of Humanin, GAS5 and miR-21/miR-103 in prostate disease risk stratification. Clinical and experimental medicine, 25(1), 279. https://doi.org/10.1007/s10238-025-01810-z

Chicago Style (17th ed.) Citation

D, Coradduzza, et al. "Diagnostic Relevance of Humanin, GAS5 and MiR-21/miR-103 in Prostate Disease Risk Stratification." Clinical and Experimental Medicine 25, no. 1 (2025): 279. https://doi.org/10.1007/s10238-025-01810-z.

MLA (9th ed.) Citation

D, Coradduzza, et al. "Diagnostic Relevance of Humanin, GAS5 and MiR-21/miR-103 in Prostate Disease Risk Stratification." Clinical and Experimental Medicine, vol. 25, no. 1, 2025, p. 279, https://doi.org/10.1007/s10238-025-01810-z.